• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管钙化的机制。

Mechanisms of vascular calcification.

作者信息

El-Abbadi Mohga, Giachelli Cecilia M

机构信息

Department of Bioengineering, University of Washington, Seattle 98195, WA. USA.

出版信息

Adv Chronic Kidney Dis. 2007 Jan;14(1):54-66. doi: 10.1053/j.ackd.2006.10.007.

DOI:10.1053/j.ackd.2006.10.007
PMID:17200044
Abstract

Vascular calcification is highly prevalent and correlated with high rates of cardiovascular mortality in chronic kidney disease patients. Recent evidence suggests that mineral, hormonal, and metabolic imbalances that promote phenotype change in vascular cells as well as deficiencies in specific mineralization inhibitory pathways may be important contributory factors for vascular calcification in these patients. This article reviews current mechanisms proposed for the regulation of vascular calcification and data supporting their potential contribution to this process in chronic kidney disease.

摘要

血管钙化在慢性肾脏病患者中非常普遍,且与心血管高死亡率相关。最近的证据表明,促进血管细胞表型改变的矿物质、激素和代谢失衡,以及特定矿化抑制途径的缺陷,可能是这些患者血管钙化的重要促成因素。本文综述了目前提出的血管钙化调节机制,以及支持其在慢性肾脏病中对这一过程潜在作用的数据。

相似文献

1
Mechanisms of vascular calcification.血管钙化的机制。
Adv Chronic Kidney Dis. 2007 Jan;14(1):54-66. doi: 10.1053/j.ackd.2006.10.007.
2
Vascular calcification and disordered mineral metabolism in dialysis patients.透析患者的血管钙化与矿物质代谢紊乱
Semin Dial. 2007 Mar-Apr;20(2):139-43. doi: 10.1111/j.1525-139X.2007.00261.x.
3
Mechanisms of vascular calcification in renal disease.肾病中血管钙化的机制。
Clin Nephrol. 2005 Feb;63(2):146-57. doi: 10.5414/cnp63146.
4
[Experimental study of the mechanism for vascular calcification in chronic kidney disease].[慢性肾脏病血管钙化机制的实验研究]
Verh K Acad Geneeskd Belg. 2008;70(4):285-303.
5
[Pathogenesis and treatment of vascular calcification in CKD].[慢性肾脏病中血管钙化的发病机制与治疗]
G Ital Nefrol. 2009 Mar-Apr;26 Suppl 45:S20-7.
6
Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.骨形态发生蛋白-7在肾脏骨中的作用及效应与慢性肾脏病中的骨-血管联系
Eur J Clin Invest. 2006 Aug;36 Suppl 2:43-50. doi: 10.1111/j.1365-2362.2006.01663.x.
7
Molecular mechanisms mediating vascular calcification: role of matrix Gla protein.介导血管钙化的分子机制:基质Gla蛋白的作用
Nephrology (Carlton). 2006 Oct;11(5):455-61. doi: 10.1111/j.1440-1797.2006.00660.x.
8
Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).钙化抑制剂在慢性肾脏病(CKD)血管钙化发病机制中的作用。
Kidney Int. 2005 Jun;67(6):2295-304. doi: 10.1111/j.1523-1755.2005.00333.x.
9
The mechanism of calcium deposition in soft tissues.
Contrib Nephrol. 2005;149:279-286. doi: 10.1159/000085689.
10
Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.与心血管疾病相关的血管钙化抑制剂,特别关注慢性肾脏病中的胎球蛋白-A。
Adv Clin Chem. 2008;46:217-62. doi: 10.1016/s0065-2423(08)00406-x.

引用本文的文献

1
Hexasodium Fytate (SNF472 or CSL525) Inhibits Ectopic Calcification in Various Pseudoxanthoma Elasticum and Calcinosis Cutis Animal Models.植酸钠六钠(SNF472或CSL525)在多种弹性假黄瘤和皮肤钙化症动物模型中抑制异位钙化。
Pharmaceuticals (Basel). 2025 Apr 14;18(4):567. doi: 10.3390/ph18040567.
2
MicroRNAs regulate the vicious cycle of vascular calcification-osteoporosis in postmenopausal women.微小 RNA 调控绝经后妇女血管钙化-骨质疏松恶性循环。
Mol Biol Rep. 2024 May 6;51(1):622. doi: 10.1007/s11033-024-09550-1.
3
CDK1 inhibition reduces osteogenesis in endothelial cells in vascular calcification.
CDK1 抑制可减少血管钙化中内皮细胞的成骨作用。
JCI Insight. 2024 Mar 8;9(5):e176065. doi: 10.1172/jci.insight.176065.
4
C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.成纤维细胞生长因子 23 的 C 端片段可改善高完整成纤维细胞生长因子 23 小鼠模型的心脏功能。
Am J Physiol Renal Physiol. 2024 Apr 1;326(4):F584-F599. doi: 10.1152/ajprenal.00298.2023. Epub 2024 Feb 1.
5
GSK3β Inhibition Reduced Vascular Calcification in Mice.GSK3β 抑制减少了小鼠的血管钙化。
Int J Mol Sci. 2023 Mar 22;24(6):5971. doi: 10.3390/ijms24065971.
6
Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis.利伐沙班在非瓣膜性心房颤动合并终末期肾病患者中的应用:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2023 Feb 7;10:1021959. doi: 10.3389/fcvm.2023.1021959. eCollection 2023.
7
Prosthetic vascular grafts engineered to combat calcification: Progress and future directions.用于对抗钙化的人工血管移植物:进展和未来方向。
Biotechnol Bioeng. 2023 Apr;120(4):953-969. doi: 10.1002/bit.28316. Epub 2022 Dec 28.
8
Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification.组蛋白乙酰化修饰酶和其他表观遗传调控因子在血管钙化中的作用。
Int J Mol Sci. 2020 May 4;21(9):3246. doi: 10.3390/ijms21093246.
9
Ferritin in Kidney and Vascular Related Diseases: Novel Roles for an Old Player.铁蛋白在肾脏及血管相关疾病中的作用:老角色的新作用
Pharmaceuticals (Basel). 2019 Jun 21;12(2):96. doi: 10.3390/ph12020096.
10
Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.了解和管理肾病患者的心房颤动
J Atr Fibrillation. 2015 Apr 30;7(6):1069. doi: 10.4022/jafib.1069. eCollection 2015 Apr-May.